ELMSFORD, N.Y., April 24, 2013 /PRNewswire/ -- BioScrip,
Inc. (NASDAQ: BIOS) (the "Company" or "BioScrip") today announced
the closing of the underwritten public offering of 14,375,000
shares of its common stock at a public offering price of
$12.00 per share, including 3,968,750
shares of common stock offered by certain selling stockholders. Of
the 14,375,000 shares offered, an aggregate of 1,875,000 shares of
common stock were sold pursuant to the underwriters' option granted
by the Company and the selling stockholders. The Company will not
receive any proceeds from the sale of shares of common stock by the
selling stockholders.
(Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
)
After payment of the underwriting discount and estimated
offering expenses, the Company received net proceeds of
approximately $118.2 million.
Jefferies LLC, Morgan Stanley & Co. LLC and SunTrust
Robinson Humphrey, Inc. acted as joint book-running managers.
Dougherty & Company and Noble Financial Capital Markets acted
as co-managers.
The securities described above have been offered by BioScrip and
the selling stockholders pursuant to a registration statement
previously filed and declared effective by the Securities and
Exchange Commission (the "SEC"). A preliminary prospectus
supplement and accompanying prospectus relating to the offering
have been filed with the SEC and are available on the SEC's website
at http://www.sec.gov. Copies of the final prospectus
supplement and accompanying prospectus relating to this offering
may be obtained from: Jefferies LLC, Attention: Equity
Syndicate Prospectus Department, 520 Madison Avenue, 12th Floor,
New York, New York, 10022,
Telephone: 877-547-6340, Email:
Prospectus_Department@Jefferies.com; Morgan Stanley & Co. LLC,
180 Varick Street, 2nd Floor, New York,
New York 10014, Attention: Prospectus Department, Telephone:
866-718-1649, Email: prospectus@morganstanley.com; or SunTrust
Robinson Humphrey, Inc., Attention: Prospectus Department, 3333
Peachtree Rd. NE, Atlanta, Georgia
30326, Telephone: 404-926-5744, Email:
STRH.Prospectus@SunTrust.com.
About BioScrip
BioScrip, Inc. provides comprehensive infusion and home care
solutions. By partnering with patients, physicians, healthcare
payors, government agencies and pharmaceutical manufacturers we are
able to provide access to infusible medications and management
solutions. Our goal is to optimize outcomes for chronic and other
complex healthcare conditions and enhance the quality of patient
life. BioScrip brings clinical competence in providing high-touch,
comprehensive infusion and nursing services to patients in the most
convenient ways possible. Through our customer services and
treatments we aim to ensure the best possible therapy outcome.
Forward Looking Statements
This press release includes statements that may constitute
"forward-looking statements," that involve substantial risks and
uncertainties. These statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. You can identify these statements by the fact
that they do not relate strictly to historical or current facts.
In some cases, forward-looking statements can be identified
by words such as "may," "should," "could," "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe,"
"predict," "potential," "continue" or comparable
terms. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors, which may cause
actual results to be materially different from any results
expressed or implied by such forward-looking statements. The
Company does not undertake any duty to update these forward-looking
statements after the date hereof, even though the Company's
situation may change in the future. All of the
forward-looking statements herein are qualified by these cautionary
statements.
SOURCE BioScrip, Inc.